Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control

Clinical Microbiology Reviews

Volumn 25, Issue 4, 2012, Pages 708-719

  Cohen, Ted ^a,b   van Helden, Paul D ^c   Wilson, Douglas ^d   Colijn, Caroline ^e   McLaughlin, Megan M ^a   Abubakar, Ibrahim ^f,g,h   Warren, Robin M ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM EXAMINATION; FALSE POSITIVE RESULT; GENE LOCUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERSPERSED REPEAT; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TUBERCULOSIS; TUBERCULOSIS CONTROL; VARIABLE NUMBER OF TANDEM REPEAT;

COINFECTION; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84867198547     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00021-12     Document Type: Article

References (114)

1. Alland D, et al. 1994. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N. Engl. J. Med. 330:1710-1716.
2. Allix C, Supply P, Fauville-Dufaux M. 2004. Utility of fast mycobacterial interspersed repetitive unit-variable number tandem repeat genotyping in clinical mycobacteriological analysis. Clin. Infect. Dis. 39:783-789.
3. Andrews JR, et al. 2008. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa. J. Infect. Dis. 198:1582-1589.
4. Andrews JR, et al. 2012. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin. Infect. Dis. 54:784-791.
5. Baldeviano-Vidalon GC, et al. 2005. Multiple infection with resistant and sensitive M. tuberculosis strains during treatment of pulmonary tuberculosis patients. Int. J. Tuberc. Lung Dis. 9:1155-1160.
6. Balmer O, Tanner M. 2011. Prevalence and implications of multiple- strain infections. Lancet Infect. Dis. 11:868-878.
7. Barczak AK, et al. 2005. In vivo phenotypic dominance in mouse mixed infections with Mycobacterium tuberculosis clinical isolates. J. Infect. Dis. 192:600-606.
8. Basu S, Orenstein E, Galvani AP. 2008. The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics. J. Infect. Dis. 198:1502-1513.
9. Bates JH, Stead WW, Rado TA. 1976. Phage type of tubercle bacilli isolated from patients with two or more sites of organ involvement. Am. Rev. Respir. Dis. 114:353-358.
10. Behr MA. 2004. Tuberculosis due to multiple strains: a concern for the patient? A concern for tuberculosis control? Am. J. Respir. Crit. Care Med. 169:554-555.
11. Biketov S, et al. 2007. The role of resuscitation promoting factors in pathogenesis and reactivation of Mycobacterium tuberculosis during intra-peritoneal infection in mice. BMC Infect. Dis. 7:146. doi:10.1186/ 1471-2334-7-146.
12. Braden CR, et al. 2001. Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin. Infect. Dis. 33:e42-e47. doi:10.1086/322635.
13. Brooks-Pollock E, Becerra MC, Goldstein E, Cohen T, Murray MB. 2011. Epidemiologic inference from the distribution of tuberculosis cases in households in Lima, Peru. J. Infect. Dis. 203:1582-1589.
14. Caminero JA, et al. 2001. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am. J. Respir. Crit. Care Med. 163:717-720.
15. Canetti G, Sutherland I, Svandova E. 1972. Endogenous reactivation and exogenous reinfection: their relative importance with regard to the development of non-primary tuberculosis. Bull. Int. Union Tuberc. 47: 116-134.
16. Chaves F, Dronda F, Alonso-Sanz M, Noriega AR. 1999. Evidence of exogenous reinfection and mixed infection with more than one strain of Mycobacterium tuberculosis among Spanish HIV-infected inmates. AIDS 13:615-620.
17. Chaves F, et al. 1997. A longitudinal study of transmission of tuberculosis in a large prison population. Am. J. Respir. Crit. Care Med. 155: 719-725.
18. Chiang CY, Riley LW. 2005. Exogenous reinfection in tuberculosis. Lancet Infect. Dis. 5:629-636.
19. Cohen T, Colijn C, Finklea B, Murray M. 2007. Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. J. R. Soc. Interface 4:523-531.
20. Cohen T, Colijn C, Murray M. 2008. Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines. Proc. Natl. Acad. Sci. U. S. A. 105: 16302-16307.
21. Cohen T, Lipsitch M, Walensky RP, Murray M. 2006. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proc. Natl. Acad. Sci. U. S. A. 103:7042-7047.
22. Cohen T, Wilson D, Wallengren K, Samuel EY, Murray M. 2011. Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa. J. Clin. Microbiol. 49:385-388.
23. Colijn C, Cohen T, Murray M. 2009. Latent coinfection and the maintenance of strain diversity. Bull. Math. Biol. 71:247-263.
24. Cosma CL, Humbert O, Ramakrishnan L. 2004. Superinfecting mycobacteria home to established tuberculous granulomas. Nat. Immunol. 5:828-835.
25. Cosma CL, Humbert O, Sherman DR, Ramakrishnan L. 2008. Trafficking of superinfecting Mycobacterium organisms into established granulomas occurs in mammals and is independent of the Erp and ESX-1 mycobacterial virulence loci. J. Infect. Dis. 198:1851-1855.
26. Cox HS, et al. 2005. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia. Respir. Res. 6:134. doi: 10.1186/1465-9921-6-134.
27. Cox HS, et al. 2007. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Clin. Infect. Dis. 44:1421-1427.
28. Das S, et al. 2004. Simultaneous infection with multiple strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis. Int. J. Tuberc. Lung Dis. 8:267-270.
29. Davies AP, et al. 2008. Resuscitation-promoting factors are expressed in Mycobacterium tuberculosis-infected human tissue. Tuberculosis (Edinb.) 88:462-468. 30.
30. de Boer AS, et al. 2000. Genetic heterogeneity in Mycobacterium tuberculosis isolates reflected in IS6110 restriction fragment length polymorphism patterns as low-intensity bands. J. Clin. Microbiol. 38:4478-4484.
31. Dickman KR, et al. 2010. Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala, Uganda. BMC Infect. Dis. 10:349. doi:10.1186/1471-2334-10-349.
32. Downing KJ, et al. 2005. Mutants of Mycobacterium tuberculosis lacking three of the five rpf-like genes are defective for growth in vivo and for resuscitation in vitro. Infect. Immun. 73:3038-3043.
33. du Plessis DG, Warren R, Richardson M, Joubert JJ, van Helden PD. 2001. Demonstration of reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: multilesional genotyping of Mycobacterium tuberculosis utilizing IS 6110 and other repetitive element-based DNA fingerprinting. Tuberculosis (Edinb.) 81:211-220.
34. Edlin BR, et al. 1992. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 326:1514-1521.
35. Fang R, et al. 2008. Mixed infections of Mycobacterium tuberculosis in tuberculosis patients in Shanghai, China. Tuberculosis (Edinb.) 88:469-473.
36. Fine PE. 2001. BCG: the challenge continues. Scand. J. Infect. Dis. 33: 243-245.
37. Ford C, et al. 2012. Mycobacterium tuberculosis- heterogeneity revealed through whole genome sequencing. Tuberculosis (Edinb.) 92: 194-201.
38. Ford CB, et al. 2011. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 43:482-486.
39. Frieden TR, et al. 1996. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 276: 1229-1235.
40. Gagneux S, Small PM. 2007. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 7:328-337.
41. Garcia de Viedma D, Alonso Rodriguez N, Andres S, Ruiz Serrano MJ, Bouza E. 2005. Characterization of clonal complexity in tuberculosis by mycobacterial interspersed repetitive unit-variable-number tandem repeat typing. J. Clin. Microbiol. 43:5660-5664.
42. Garcia de Viedma D, Marin M, Ruiz MJ, Bouza E. 2004. Analysis of clonal composition of Mycobacterium tuberculosis isolates in primary infections in children. J. Clin. Microbiol. 42:3415-3418.
43. Gillespie SH. 2002. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob. Agents Chemother. 46:267-274.
44. Gomes MG, Franco AO, Gomes MC, Medley GF. 2004. The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy. Proc. Biol. Sci. 271:617-623.
45. Grzybowski S, Galbraith JD, Dorken E. 1976. Chemoprophylaxis trial in Canadian Eskimos. Tubercle 57:263-269.
46. Gupta RK, Srivastava BS, Srivastava R. 2010. Comparative expression analysis of rpf-like genes of Mycobacterium tuberculosis H37Rv under different physiological stress and growth conditions. Microbiology 156: 2714-2722.
47. Henao-Tamayo M, et al. 2012. A mouse model of tuberculosis reinfection. Tuberculosis (Edinb.) 92:211-217.
48. Hofmann-Thiel S, et al. 2009. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur. Respir. J. 33:368-374.
49. Huang HY, et al. 2010. Mixed infection with Beijing and non-Beijing strains and drug resistance pattern of Mycobacterium tuberculosis. J. Clin. Microbiol. 48:4474-4480.
50. Huyen MN, et al. 2012. Mixed tuberculosis infections in rural South Vietnam. J. Clin. Microbiol. 50:1586-1592.
51. Kamerbeek J, et al. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J.Clin. Microbiol. 35:907-914.
52. Kana BD, et al. 2008. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol. Microbiol. 67:672-684.
53. Kent PT, Kubica GP. 1985. Public health mycobacteriology: a guide for the level III laboratory. Centers for Disease Control, Atlanta, GA.
54. Klovdahl AS, et al. 2001. Networks and tuberculosis: an undetected community outbreak involving public places. Soc. Sci. Med. 52:681-694.
55. Kong Y, et al. 2007. Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. J. Clin. Microbiol. 45:409-414.
56. Lambert ML, et al. 2003. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect. Dis. 3:282-287.
57. Lazzarini LC, et al. 2012. Mycobacterium tuberculosis spoligotypes that may derive from mixed strain infections are revealed by a novel computational approach. Infect. Genet. Evol. 12:798-806.
58. Lew W, Pai M, Oxlade O, Martin D, Menzies D. 2008. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann. Intern. Med. 149:123-134.
59. Mallard K, et al. 2010. Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi. J. Clin. Microbiol. 48:4512-4518.
60. Mankiewicz E, Liivak M. 1975. Phage types of Mycobacterium tuberculosis in cultures isolated from Eskimo patients. Am. Rev. Respir. Dis. 111:307-312.
61. Martin A, Herranz M, Ruiz Serrano MJ, Bouza E, Garcia de Viedma D. 2010. The clonal composition of Mycobacterium tuberculosis in clinical specimens could be modified by culture. Tuberculosis (Edinb.) 90: 201-207.
62. Mathema B, Kurepina N, Fallows D, Kreiswirth BN. 2008. Lessons from molecular epidemiology and comparative genomics. Semin. Respir. Crit. Care Med. 29:467-480.
63. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. 2006. Molecular epidemiology of tuberculosis: current insights. Clin. Microbiol. Rev. 19: 658-685.
64. McShane H, et al. 2012. BCG: myths, realities, and the need for alternative vaccine strategies. Tuberculosis (Edinb.) 92:283-288.
65. Mills HL, Cohen T, Colijn C. 2011. Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure. J. R. Soc. Interface 8:1510-1520.
66. Mokrousov I, et al. 2009. Penitentiary population of Mycobacterium tuberculosis in Kyrgyzstan: exceptionally high prevalence of the Beijing genotype and its Russia-specific subtype. Infect. Genet. Evol. 9:1400-1405.
67. Mollenkopf HJ, Kursar M, Kaufmann SH. 2004. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Mycobacterium bovis bacille Calmette-Guerin induce equal protection. J. Infect. Dis. 190:588-597.
68. Moreira AL, et al. 2002. Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice. Infect. Immun. 70:2100-2107.
69. Moro ML, et al. 1998. An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. Italian Multidrug-Resistant Tuberculosis Outbreak Study Group. AIDS 12: 1095-1102.
70. Mukamolova GV, et al. 2002. A family of autocrine growth factors in Mycobacterium tuberculosis. Mol. Microbiol. 46:623-635.
71. Munch Z, et al. 2003. Tuberculosis transmission patterns in a high-incidence area: a spatial analysis. Int. J. Tuberc. Lung Dis. 7:271-277.
72. Murray M, Nardell E. 2002. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. Bull. World Health Organ. 80:477-482.
73. Narayanan S, et al. 2010. Impact of HIV infection on the recurrence of tuberculosis in South India. J. Infect. Dis. 201:691-703.
74. Navarro Y, et al. 2011. Systematic survey of clonal complexity in tuberculosis at a populational level and detailed characterization of the isolates involved. J. Clin. Microbiol. 49:4131-4137.
75. Niemann S, Richter E, Rusch-Gerdes S, Schlaak M, Greinert U. 2000. Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis. Emerg. Infect. Dis. 6:548-551.
76. Pavlic M, Allerberger F, Dierich MP, Prodinger WM. 1999. Simultaneous infection with two drug-susceptible Mycobacterium tuberculosis strains in an immunocompetent host. J. Clin. Microbiol. 37:4156-4157.
77. Repique CJ, Li A, Collins FM, Morris SL. 2002. DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge. Infect. Immun. 70:3318-3323.
78. Richardson M, et al. 2002. Multiple Mycobacterium tuberculosis strains in early cultures from patients in a high-incidence community setting. J. Clin. Microbiol. 40:2750-2754.
79. Rivero A, et al. 2001. High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B. Clin. Infect. Dis. 32:159-161.
80. Romeyn JA. 1970. Exogenous reinfection in tuberculosis. Am. Rev. Respir. Dis. 101:923-927.
81. Rullan JV, et al. 1996. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain. Emerg. Infect. Dis. 2:125-129.
82. Russell-Goldman E, Xu J, Wang X, Chan J, Tufariello JM. 2008. A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes. Infect. Immun. 76:4269-4281.
83. Sacks LV, Pendle S, Orlovic D, Blumberg L, Constantinou C. 1999. A comparison of outbreak- and nonoutbreak-related multidrug-resistant tuberculosis among human immunodeficiency virus-infected patients in a South African hospital. Clin. Infect. Dis. 29:96-101.
84. Schurch AC, van Soolingen D. 2012. DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencing. Infect. Genet. Evol. 12:602-612.
85. Sergeev R, Colijn C, Cohen T. 2011. Models to understand the population-level impact of mixed strain M. tuberculosis infections. J. Theor. Biol. 280:88-100.
86. Shamputa IC, et al. 2006. Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia. Respir. Res. 7:99. doi:10.1186/1465-9921-7-99.
87. Shamputa IC, et al. 2004. Genotypic and phenotypic heterogeneity among Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients. J. Clin. Microbiol. 42:5528-5536.
88. Shimao T. 1987. Drug resistance in tuberculosis control. Tubercle 68:5-18.
89. Small PM, et al. 1994. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N. Engl. J. Med. 330:1703-1709.
90. Snider DE, Jr, Jones WD, Good RC. 1984. The usefulness of phage typing Mycobacterium tuberculosis isolates. Am. Rev. Respir. Dis. 130: 1095-1099.
91. Sreevatsan S, et al. 1997. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. U. S. A. 94:9869-9874.
92. Stavrum R, et al. 2009. High diversity of Mycobacterium tuberculosis genotypes in South Africa and preponderance of mixed infections among ST53 isolates. J. Clin. Microbiol. 47:1848-1856.
93. Stead WW. 1967. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am. Rev. Respir. Dis. 95:729-745.
94. Streicher EM, et al. 2012. Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing. Antimicrob. Agents Chemother. 56:2420-2427.
95. Supply P, et al. 2001. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J. Clin. Microbiol. 39:3563-3571.
96. Sutherland I. 1976. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv. Tuberc. Res. 19:1-63.
97. Taylor JL, et al. 2003. Pulmonary necrosis resulting from DNA vaccination against tuberculosis. Infect. Immun. 71:2192-2198.
98. Theisen A, et al. 1995. Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of Mycobacterium tuberculosis. Lancet 345: 1512. doi:10.1016/S0140-6736(95)91073-5.
99. Tilman D. 1994. Competition and biodiversity in spatially structured habitats. Ecology 75:2-16.
100. Umubyeyi AN, et al. 2007. Molecular investigation of recurrent tuberculosis in patients from Rwanda. Int. J. Tuberc. Lung Dis. 11:860-867.
101. Uys PW, van Helden PD, Hargrove JW. 2009. Tuberculosis reinfection rate as a proportion of total infection rate correlates with the logarithm of the incidence rate: a mathematical model. J. R. Soc. Interface 6:11-15.
102. Valway SE, et al. 1994. Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am. J. Epidemiol. 140:113-122.
103. van der Spuy GD, et al. 2003. Use of genetic distance as a measure of ongoing transmission of Mycobacterium tuberculosis. J. Clin. Microbiol. 41:5640-5644.
104. van Embden JD, et al. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
105. van Helden PD. 2002. Molecular epidemiology of TB: challenging dogmas and asking new questions. IUBMB Life 53:219-223.
106. van Rie A, et al. 2005. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am. J. Respir. Crit. Care Med. 172:636-642.
107. van Rie A, et al. 1999. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 341:1174-1179.
108. Verver S, et al. 2004. Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet 363:212-214.
109. Vynnycky E, Fine PE. 1997. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol. Infect. 119:183-201.
110. Wang JY, et al. 2011. Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain. Clin. Microbiol. Infect. 17:1239-1245.
111. Wang JY, et al. 2007. Prediction of the tuberculosis reinfection proportion from the local incidence. J. Infect. Dis. 196:281-288.
112. Warren RM, et al. 2004. Patients with active tuberculosis often have different strains in the same sputum specimen. Am. J. Respir. Crit. Care Med. 169:610-614.
113. Yeh RW, Hopewell PC, Daley CL. 1999. Simultaneous infection with two strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis. Int. J. Tuberc. Lung Dis. 3:537-539.
114. Zhang P, Sandland GJ, Feng Z, Xu D, Minchella DJ. 2007. Evolutionary implications for interactions between multiple strains of host and parasite. J. Theor. Biol. 248:225-240.